GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Viveon Health Acquisition Corp (OTCPK:VHAQU) » Definitions » Research & Development

VHAQU (Viveon Health Acquisition) Research & Development : $0.00 Mil (TTM As of Dec. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Viveon Health Acquisition Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Viveon Health Acquisition's Research & Development for the three months ended in Dec. 2022 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.


Viveon Health Acquisition Research & Development Historical Data

The historical data trend for Viveon Health Acquisition's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viveon Health Acquisition Research & Development Chart

Viveon Health Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Research & Development
- - -

Viveon Health Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Research & Development Get a 7-Day Free Trial Premium Member Only - - - - -

Viveon Health Acquisition Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viveon Health Acquisition  (OTCPK:VHAQU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Viveon Health Acquisition Research & Development Related Terms

Thank you for viewing the detailed overview of Viveon Health Acquisition's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Viveon Health Acquisition Business Description

Traded in Other Exchanges
N/A
Address
3480 Peachtree Road NE, 2nd Floor, Suite 112, Atlanta, GA, USA, 30326
Website
Viveon Health Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.
Executives
Demetrios G. Logothetis director C/O GIBSON, DEAL & FLETCHER, PC, 3953, NORCROSS GA 30092
Lishan Aklog director 420 LEXINGTON AVENUE, SUITE 300, NEW YORK NY 10171
Romilos Papadopoulos director, 10 percent owner, officer: CFO and Treasurer C/O XETHANOL CORPORATION, 3348 PEACHTREE ROAD NE, BLDG 200, #250, ATLANTA GA 30326
John Douglas Craft director C/O GIDSON, DEAL & FLETCHER, PC, 3953 HOLCOMB BRIDGE ROAD, NORCROSS GA 30092
Brian J. Cole director C/O GIBSON, DEAL, AND FLETCHER, P. C., 3953 HOLCOMB BRIDGE ROAD, NORCROSS GA 30092
Jagi Gill director, 10 percent owner, officer: CEO and President C/O GIDSON, DEAL & FLETCHER, PC, 395, NORCROSS GA 30092
Viveon Health, Llc 10 percent owner C/O GIDSON, DEAL & FLETCHER, PC, 39, NORCROSS NY 30092

Viveon Health Acquisition Headlines

From GuruFocus